Protalix BioTherapeutics (PLX) Shareholder's Equity Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 305.54% |
| Dec 31, 2025 | 86.94% |
| Sep 30, 2025 | 87.53% |
| Jun 30, 2025 | 91.71% |
| Mar 31, 2025 | 100.32% |
| Dec 31, 2024 | 109.23% |
| Sep 30, 2024 | 434.02% |
| Jun 30, 2024 | 95.23% |
| Mar 31, 2024 | 27.11% |
| Dec 31, 2023 | 48.00% |
| Sep 30, 2023 | 46.56% |
| Jun 30, 2023 | 46.15% |
| Mar 31, 2023 | 26.67% |
| Dec 31, 2022 | 46.71% |
| Sep 30, 2022 | 45.43% |
| Jun 30, 2022 | 47.28% |
| Mar 31, 2022 | 49.99% |
| Dec 31, 2021 | 51.49% |
| Sep 30, 2021 | 26.09% |
| Jun 30, 2021 | 27.85% |
| Mar 31, 2021 | 34.06% |
| Dec 31, 2020 | 2.82% |
| Sep 30, 2020 | -8.52% |
| Jun 30, 2020 | -18.93% |
| Mar 31, 2020 | 23.31% |
| Dec 31, 2019 | -91.86% |
| Sep 30, 2019 | -67.40% |
| Jun 30, 2019 | -103.77% |
| Mar 31, 2019 | -190.78% |
| Dec 31, 2018 | -90.04% |
| Sep 30, 2018 | 11.22% |
| Jun 30, 2018 | 13.10% |
| Mar 31, 2018 | 16.63% |
| Dec 31, 2017 | 19.08% |
| Mar 31, 2017 | -26.81% |
| Dec 31, 2016 | 28.24% |
| Sep 30, 2016 | 3.31% |
| Jun 30, 2016 | 12.70% |
| Mar 31, 2016 | 34.29% |
| Dec 31, 2015 | 73.68% |
| Sep 30, 2015 | -153.84% |
| Jun 30, 2015 | -117.46% |
| Mar 31, 2015 | -111.58% |
| Dec 31, 2014 | -28.71% |
| Mar 31, 2014 | -109.06% |
| Dec 31, 2013 | -33.51% |
| Sep 30, 2013 | -67.72% |
| Jun 30, 2013 | -97.58% |